Leidos Biomedical Research operates the Frederick National Laboratory for Cancer Research (FNLCR) on behalf of the National Cancer Institute. For more than 25 years, our scientists and technical experts have supported cancer breakthroughs, infectious disease response, and biomedical innovation through work in genomics, proteomics, virology, and clinical operations.
Biomedical Research and Innovation
Advancing research in cancer, infectious disease, and human performance to improve health on Earth and in space
Leidos brings together scientists, technology, and experience to advance biomedical research and improve health. From managing one of the nation’s only Federally Funded Research and Development Centers for cancer research to protecting astronaut health in space, our teams move discovery into action, improve treatment, and help solve complex health challenges.
Our Capabilities
From human performance to cancer and infectious disease, our research advances health, safety, and exploration.
Human Performance & Health Optimization
Supporting readiness and resilience through science and technology. Our work helps prevent injuries, build resilience, and sustain peak performance—at home, in the field, and during recovery.
Spaceflight Health & Performance Services
Protecting astronaut health and safety for missions to the moon, Mars, and beyond. We support training, hardware development, medical research, and post-flight activities to address the unique challenges of human spaceflight.
Scientific Program Execution
Scientific, operational, and regulatory support to move research into practice. We help our customers manage laboratories, coordinate clinical trials, and meet regulatory requirements so discoveries can move quickly and safely from research to real-world use.
Related News
Leidos donates $2.5 million to The Children’s Inn at NIH to expand support for pediatric research
Read Press Release